cholecalciferol and Heart-Defects--Congenital

Consistent with accepted practice in stable ambulatory populations, the majority of ICU research has evaluated vitamin D status using a single blood 25-hydroxyvitamin D (25(OH)D) level. Only a limited number of ICU studies have measured the active hormone, 1,25-dihydroxyvitamin D (calcitriol) and none have used change in calcitriol levels to evaluate axis functioning. The objective of this study was to describe the impact of Congenital Heart Disease (CHD) surgery on calcitriol levels and evaluate the relationship between change in postoperative levels and clinical course.. Secondary analysis of a prospective cohort study of 56 children undergoing surgery for CHD.. Mean calcitriol levels dropped from 122.3 ± 69.1 pmol/L preoperatively to 65.3 ± 36.5 pmol/L (p < 0.0001) at PICU admission. The majority (61%, n = 34) were unable to increase calcitriol levels in the 48 h immediately following surgery. Post operative trend in calcitriol was inversely related to cardiovascular dysfunction, fluid requirements, ventilatory support and PICU length of stay (p < 0.01).. CHD patients had significant dysfunction of the vitamin D axis immediately postoperatively, demonstrated by both a significant intraoperative decline in calcitriol and inability to increase levels. Interventional research will be required to determine whether the use of calcitriol, in addition to cholecalciferol, reduces postoperative illness severity.

Topics: Calcitriol; Cardiac Surgical Procedures; Child; Child, Preschool; Cholecalciferol; Critical Care; Female; Heart; Heart Defects, Congenital; Hospitals, Pediatric; Humans; Intensive Care Units, Pediatric; Linear Models; Male; Outcome Assessment, Health Care; Patient Admission; Pediatrics; Postoperative Period; Prospective Studies; Vitamin D